Divisadero Street Capital Management sold 2.26 million shares of Indivior (INDV) for approximately $74.76 million in Q1 2026, reducing its stake to 521,083 shares. The sale appears to be profit-taking after the stock surged nearly 200% over the past year. Despite the fund's exit, Indivior's fundamentals remain strong with Q1 revenue up 19% year-over-year to $317 million and SUBLOCADE sales jumping 32% to $232 million, prompting management to raise 2026 guidance.

The Dow Jones Industrial Average reached a record high above 50,600 while the Nasdaq 100 declined 0.7% on Wednesday. Oil prices fell sharply below $90 per barrel following reports of potential Iran negotiations, benefiting travel and leisure stocks. The S&P 500 edged slightly lower as semiconductor stocks retreated, while consumer discretionary and hospitality sectors led gains.

The article examines whether Celsius (CELH) stock represents an undervalued buying opportunity. It notes that a new Costco offering is concerning Celsius investors, while the company's sales continue to grow. The stock has declined 50% from its highs as of the publication date in May 2026.

The article compares two growth stocks in the beverage industry: Celsius Holdings, an energy drink company bolstered by its acquisition of Alani Nu, and Dutch Bros, a rapidly expanding coffee chain. Celsius projects 20% revenue growth and 55% EPS growth through 2028, while Dutch Bros shows stronger operational momentum with 27.9% revenue growth and 76.4% net income surge in 2025. The author recommends Dutch Bros as the better choice due to its more sustainable competitive advantages and lower risk profile compared to Celsius's more competitive market.

Celsius Holdings, once a high-flying energy drink stock that surged 7,330% by March 2024, has fallen 65% from its peak. While the company benefits from growing consumer demand for sugar-free, health-focused beverages and the acquisition of Alani Nu, it faces intense competition from larger players like Red Bull and Monster Beverage. Trading at 22.5x 2026 EPS with projected 55% EPS growth through 2028, Celsius presents a high-risk, potentially high-reward opportunity, though valuation contraction is likely as growth moderates.

Celsius stock has experienced a significant decline, with competition from Costco spooking investors. The company is still in early stages of international expansion. The article examines whether this drop presents a buying opportunity for investors.

Celsius stock has fallen 21% over six trading days due to Costco's entry into the energy drink market and broader market weakness. However, analysts argue the selloff is overdone. The article highlights three reasons for optimism: Costco's Kirkland Signature drinks lack Celsius's weight-loss benefits and have limited distribution, Celsius has strong growth momentum with the Alani Nu acquisition, and the stock trades at a reasonable valuation of 16x next year's earnings despite consistent earnings beat performance.

Celsius Holdings stock has plummeted 49% from its 52-week high to $34 per share, primarily due to Costco launching a cheaper private-label energy drink competitor. While the company reported strong Q4 sales of $722 million and successful acquisitions of Alani Nu and Rockstar Energy, the analyst remains cautious due to valuation concerns and intense competitive pressures in the beverage market. Despite impressive growth, the stock's forward P/E ratio in the twenties doesn't justify the risks in an increasingly competitive environment.

Celsius Holdings is positioned for significant growth with 86% full-year sales growth in 2025, driven by an expanded partnership with PepsiCo in North America and early-stage international expansion. The company's international business, though currently small at $93 million in sales, represents a major growth opportunity as it expands into new markets like Spain.

MIG Capital sold $37.41 million worth of Sotera Health shares (2.26 million shares) in Q4 2025, reducing its stake to 5.88% of AUM. Despite the trim, the fund maintains a significant position in the sterilization and lab testing company. Sotera posted its 20th consecutive year of revenue growth with 5.7% sales increase to $1.16 billion in 2025, while net income nearly doubled to $78 million. The company projects 5-6.5% revenue growth for 2026.

Celsius (CELH) has delivered a spectacular 6,300% return over the past decade through strong revenue growth, strategic acquisitions (Alani Nu and Rockstar Energy), and a PepsiCo distribution partnership. However, the bull case faces headwinds from intense competition with Red Bull and Monster Beverage commanding larger market shares, a lack of durable competitive moat, expensive valuation at 28.4x forward P/E, and analyst expectations for only 10% annual earnings growth through 2028. The author concludes the stock is not a buy at current levels.

Ten large-cap stocks experienced significant declines during the week of March 2-6, 2026, driven by weak earnings, lowered guidance, geopolitical tensions, rising yields, and AI-spending concerns. Notable losers include Lumentum Holdings (down 24.65%), Corning (down 21.91%), MongoDB (down 16.23%), and Celsius Holdings (down 17.86%), among others.